Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Metadata
Title
Updated statistical data for malignant melanoma in Japan
Authors
K. Ishihara
T. Saida
A. Yamamoto
The Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society, Matsumoto, Japan
Publication date
01-06-2001
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 3/2001
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/PL00012091

Other articles of this Issue 3/2001

International Journal of Clinical Oncology 3/2001 Go to the issue

ORIGINAL ARTICLE

Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: a questionnaire survey in Japan

ORIGINAL ARTICLE

3-Hour infusion of single-agent paclitaxel for recurrent ovarian cancer

ORIGINAL ARTICLE

Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy

CASE REPORT

Spontaneous regression of recurrent hepatocellular carcinoma after TAE: possible mechanisms of immune mediation

ORIGINAL ARTICLE

Clinicopathological study of carcinomas of the lip and the mucosa of the upper and lower lips

ORIGINAL ARTICLE

Myofascial flap without skin for intra-oral reconstruction 2: clinical studies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits